SCHEMBL1336740

SCHEMBL1336740

COc1ccc2nc(C=O)ccc2c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2R P25116 1/20 0.46
KMT2A Q03164 3/20 0.39
CYP19A1 P11511 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
CYP17A1 P05093 1/20 0.38
S1PR4 O95977 2/20 0.37
ALDH1A1 P00352 4/20 0.37
TDO2 P48775 1/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
CCR1 P32246 1/20 0.35
TSHR P16473 1/20 0.35
PRKDC P78527 1/20 0.34
ERN1 O75460 1/20 0.34
GLA P06280 1/20 0.34
PDE10A Q9Y233 1/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12132125 0.83 ALDH1A1 (0.39) F2RKMT2AALDH1A1TDO2MAPT
SCHEMBL1336684 0.81 PRKDC (0.41) F2RKMT2ACYP19A1CYP11B1CYP11B2
SCHEMBL1337699 0.81 ALDH1A1 (0.37) F2RKMT2AS1PR4ALDH1A1TDO2
SCHEMBL1337889 0.78 MEN1 (0.49) KMT2AALDH1A1MAPTMEN1PRKDC
SCHEMBL28449950 0.78 PDE10A (0.51) KMT2AALDH1A1MAPTMEN1ERN1
SCHEMBL1337919 0.77 MEN1 (0.44) KMT2ACYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL29957260 0.76 S1PR4 (0.53) KMT2AS1PR4ALDH1A1MAPTMEN1
SCHEMBL1337920 0.75 F2R (0.39) F2RKMT2AALDH1A1TDO2MAPT
SCHEMBL4898660 0.72 ALDH1A1 (0.50) KMT2AS1PR4ALDH1A1MAPTTSHR
SCHEMBL1337297 0.72 PDE3B (0.46) CYP19A1ALDH1A1ERN1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-11-10 US disclosed
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275643-A1 AROYLQUINOLINE COMPOUNDS TUBA1C, TUBB1, TUBB3 F2R 3541/4885KMT2A 1581/4885CYP19A1 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.